News | April 12, 2026
EMA gives green light to warmer & simpler delivery rules for Wegovy injection
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The event also featured discussions on emerging trends in joint replacement surgery
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Subscribe To Our Newsletter & Stay Updated
